insights_auto
Waarom is ALMKT gedaald 4,22%?
Meer informatiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€ 0,089
arrow_downward
-4,22%(-0,0039) 1D
18 nov, 17:35:09 GMT+1 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ALMKT genereren…
Openen
€ 0,09
Hoog
€ 0,09
Laag
€ 0,09
Beursw.
17,68 mln.
Gem. vol.
481,42K
Volume
152,44K
Koers/winst-verhouding
0,75
52 wk hoog
€ 0,23
52 wk laag
€ 0,07
WPA
€ 0,12
Uitstaande aandelen
195,26 mln.
Aantal medewerkers
56
Openen
€ 0,09
Hoog
€ 0,09
Laag
€ 0,09
Beursw.
17,68 mln.
Gem. vol.
481,42K
Volume
152,44K
Koers/winst-verhouding
0,75
52 wk hoog
€ 0,23
52 wk laag
€ 0,07
WPA
€ 0,12
Uitstaande aandelen
195,26 mln.
Aantal medewerkers
56
Nieuwsartikelen
Van webbronnen en nieuwspartners
seMissourian
·
1 uur geleden
Fifth straight drop for S&P 500 drags Wall Street to its longest losing streak since June
Hedgeye
·
13 uur geleden
Why Negative Gamma Has Taken the Brakes Off the S&P 500
The Motley Fool
·
4 uur geleden
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Barron's
·
3 uur geleden
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
Profiel
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Over Mauna Kea Technologies SA
CEOSacha Loiseau
Medewerkers56
Opgericht2000
Hoofdkantoor-
SectorHealth Care
Industrie-
Websitemaunakeatech.com